• Title/Summary/Keyword: Treatment Efficacy

Search Result 4,438, Processing Time 0.033 seconds

Orthodontic pain control following arch wire placement; a comparison between pre-emptive tenoxicam and chewing gum: a randomized clinical trial

  • Basam, Lakshman Chowdary;Singaraju, Gowri Sankar;Obili, Sobitha;Keerthipati, Thejasree;Basam, Ram Chowdary;Prasad, Mandava
    • Journal of Dental Anesthesia and Pain Medicine
    • /
    • v.22 no.2
    • /
    • pp.107-116
    • /
    • 2022
  • Background: Pain during fixed orthodontic treatment can have a detrimental effect on patient treatment compliance. To overcome this, there is a definite need to establish the best pain-relieving methods suitable for orthodontic patients in terms of efficacy and use. The objective of this study was to compare the effect of chewing gum and pre-emptive tenoxicam on pain after initial archwire placement and to evaluate the pain perceptions of orthodontic patients in the two groups while performing various functions at specific time intervals. Methods: Forty-two patients were selected and randomly divided into two groups: group A (chewing gum) and group B (pre-emptive tenoxicam). Pain perception was documented by patients immediately; at 4 h; at bedtime on the day of archwire placement; the next morning; at 24 h; and at bedtime on the 2nd, 3rd, and 7th day after the initial archwire placement. Pain scores were noted during fitting of the posterior teeth, biting, and chewing using a visual analog scale. The data obtained were subjected to statistical analysis. Results: Group A showed a significant increase in pain until the next morning while fitting the posterior teeth, biting, and chewing [36.2, 52.0, 33.4, respectively]], followed by a gradual decrease by the 7th day. Group B showed a significant increase in pain at bedtime on biting, with a peak value of 47.5. Pain on chewing, fitting posterior teeth, peaked the morning of the next day (100.0, 45.0). The Freidman test showed a statistically significant difference with a p-value of < 0.01. Higher pain scores were observed while chewing and biting compared with that while fitting the posterior teeth in both groups. The overall comparison of pain control between the two groups was not statistically significant [P > 0.05] between the two groups. Conclusions: Chewing gum was not inferior to pre-emptive tenoxicam. Thus, chewing gum is a non-pharmacological alternative to analgesics for orthodontic pain control that eliminates the chance of adverse reactions and can be used in the absence of adult observation.

Behavioral Disruption of Frankliniella occidentalis Adults by a Synthetic Contact Pheromone and its Application to Control the Insect Pest (합성 접촉페로몬을 이용한 꽃노랑총채벌레의 성충 행동 교란과 이를 이용한 방제기술)

  • Hyunje Park;Chulyoung Kim;Seongchae Jung;Youngun, Kim;Yonggyun Kim
    • Korean journal of applied entomology
    • /
    • v.62 no.3
    • /
    • pp.161-169
    • /
    • 2023
  • Thrips are usually not exposed to insecticide spray due to hiding at holes, gaps, or crevices of host plants with their relatively small body sizes. This study devised a strategy to use a contact pheromone to suppress the seclusive behavior of the thrips, A contact pheromone identified as 7-methyltricosane (7TM) in the western flower thrips, Frankliniella occidentalis, was added to the diet to test the preference of the thrips. Although 7TM did not change the larval behavior, it significantly induced the avoiding behavior in male adults. In contrast, the contact pheromone was preferred by the female adults. Similar behavioral changes were also observed in another flower thrips, Frankliniella intonsa. Based on the behavioral changes induced by the contact pheromone, a mixture of 7TM and insecticide was applied to thrips infesting hot peppers in field conditions. Compared to spinetoram treatment, its mixture treatment with 7TM enhanced the control efficacy against thrips. Interestingly, 7TM treatment alone also gave slight reduction in F. intonsa density, suggesting a behavioral disruption of thrips by the contact pheromone. This study suggests a novel technology to control insect pests using contact pheromone by suppressing the seclusive behavior to avoid exposure to insecticide spray.

Progress in Nanofiltration-Based Capacitive Deionization (나노여과 기반 용량성 탈이온화의 진전)

  • Jeong Hwan Shim;Rajkumar Patel
    • Membrane Journal
    • /
    • v.34 no.2
    • /
    • pp.87-95
    • /
    • 2024
  • Recent studies explore a wide array of desalination and water treatment methods, encompassing membrane processes such as reverse osmosis (RO), nanofiltration (NF), and electrodialysis (ED) to advanced capacitive deionization (CDI) and its membrane variant (MCDI). Comparative analyses reveal ED's cost-effectiveness in low-salinity scenarios, while hybrid systems (NF-MCDI, RO-NF-MCDI) show improved salt removal and energy efficiency. Novel ion separation methods (NF-CDI, NF-FCDI) offer enhanced efficacy and energy savings. These studies also highlight the efficiency of these methods in treating complex wastewater specific to various industries. Environmental impact assessments emphasize the need for sustainability in system selection. Additionally, the integration of microfabricated sensors into membranes allows real-time monitoring, advancing technology development. These studies underscore the variety and promise of emerging desalination and water treatment technologies. They provide valuable insights for enhancing efficiency, minimizing energy usage, tackling industry-specific issues, and innovating to surpass conventional method limitations. The future of sustainable water treatment appears bright, with continual advancements focused on improving efficiency, minimizing environmental impact, and ensuring adaptability across diverse applications.

Clinical Results of Drug-Coated Balloon Treatment in a Large-Scale Multicenter Korean Registry Study

  • Sang Yeub Lee;Yun-Kyeong Cho;Sang-Wook Kim;Young-Joon Hong;Bon-Kwon Koo;Jang-Whan Bae;Seung-Hwan Lee;Tae Hyun Yang;Hun Sik Park;Si Wan Choi;Do-Sun Lim;Soo-Joong Kim;Young Hoon Jeong;Hyun-Jong Lee;Kwan Yong Lee;Eun-Seok Shin;Ung Kim;Moo Hyun Kim;Chang-Wook Nam;Seung-Ho Hur;Doo-Il Kim; Stent Failure Research Group (SFR) Drug coated balloon (DCB) registry investigators
    • Korean Circulation Journal
    • /
    • v.52 no.6
    • /
    • pp.444-454
    • /
    • 2022
  • Background and Objectives: The aim of this study was to demonstrate the efficacy and safety of treatment with drug-coated balloon (DCB) in a large real-world population. Methods: Patients treated with DCBs were included in a multicenter observational registry that enrolled patients from 18 hospitals in Korea between January 2009 and December 2017. The primary outcome was target lesion failure (TLF) defined as a composite of cardiovascular death, target vessel myocardial infarction, and clinically indicated target lesion revascularization at 12 months. Results: The study included 2,509 patients with 2,666 DCB-treated coronary artery lesions (1,688 [63.3%] with in-stent restenosis [ISR] lesions vs. 978 [36.7%] with de novo lesions). The mean age with standard deviation was 65.7±11.3 years; 65.7% of the patients were men. At 12 months, the primary outcome, TLF, occurred in 179 (6.7%), 151 (8.9%), 28 (2.9%) patients among the total, ISR, and de novo lesion populations, respectively. A history of hypertension, diabetes, acute coronary syndrome, previous coronary artery bypass graft, reduced left ventricular ejection fraction, B2C lesion and ISR lesion were independent predictors of 12 months TLF in the overall study population. Conclusions: This large multicenter DCB registry study revealed the favorable clinical outcome of DCB treatment in real-world practice in patient with ISR lesion as well as small de novo coronary lesion.

A Case Report of Psycho-Therapeutic Approach in Combined Korean Medicine Treatment for Psychiatric Symptoms in a Patient with Major Depressive Disorder and Cerebellar Ataxia (주요우울장애와 소뇌실조증으로 진단된 환자의 정신 증상에 대한 한의 복합 치료에서의 정신요법적 접근 1례)

  • Hye Jeong Kook;Dong Hoon Kang;Jun Young Hur;Ho Ryong Yoo;In Chul Jung
    • Journal of Oriental Neuropsychiatry
    • /
    • v.35 no.3
    • /
    • pp.315-331
    • /
    • 2024
  • Objectives: To report the effectiveness of a comprehensive Korean medical approach, incorporating acupuncture, herbal medicine, Chuna therapy, and traditional Korean psychotherapy, in the management of a patient with cerebellar ataxia and major depressive disorder. Methods: A 45-year-old female patient diagnosed with cerebellar ataxia and major depressive disorder received a comprehensive Korean medicine treatment, including acupuncture, moxibustion, herbal medicine, Chuna therapy, and traditional Korean psychotherapy such as Giungoroen therapy, IiGyeungByunQi therapy, M&L therapy, and Emotional Freedom Technique (EFT). The efficacy was assessed through both subjective symptom reports and a range of psychological assessment tools, including the Minnesota Multiphasic Personality Inventory-2 (MMPI-2), Korean Symptom Checklist-95 (KSCL-95), Korean Beck Depression Inventory-II (K-BDI-II), Spielberger's State-Trait Anxiety Inventory XYZ form (STAI-XYZ), Korean version of the State-Trait Anger Expression Inventory (STAXI-K), Padua Inventory-Washington State University Revision (PI-WSUR), Penn State Worry Questionnaire (PSWQ), and the Korean Version of the Insomnia Severity Index (ISI-K). Results: Throughout treatment, the patient experienced marked improvements in physical symptoms, notably dizziness, and gait instability. Psychological evaluations demonstrated significant reductions in anxiety, depression, and insomnia. The overall quality of life was enhanced, with sustained benefits observed during follow-up assessments. Conclusions: This case suggests that a comprehensive Korean medicine approach that integrates acupuncture, herbal medicine, Chuna therapy, and traditional Korean psychotherapy may be effective in alleviating both physical and psychological symptoms associated with cerebellar ataxia and major depressive disorder.

Praziquantel($Distocide^{\circledR}$) in Treatment of Clonorchis sinensis Infection (국산 Praziquantel($디스토시드^{\circledR}$)의 간흡충증에 대한 효과)

  • 서병고;이순형금종일홍성태
    • Parasites, Hosts and Diseases
    • /
    • v.21 no.2
    • /
    • pp.241-245
    • /
    • 1983
  • PraziquantEI ($Distocide^{\circledR}$), the KcrEan product, was tEstEd for its safety and Efficacy in treatmEnt of Clonorchis sinensiJ infccticn during the period from April to SeptembEr, 1983 in Korea. A total of 55 egg positive cases were selected and treated with the regimen of 25 mg/kg t.i.d. for 1 day (total 75 mg/kg). The follow-up stool examination was done in 47 cases by cellophane thir;k smear and Stoll's egg counting techniques. The 8 uncured cases were treated again with the same regimen. The laboratory tests for blood picture and liver function were done in 27 cases and compared before and after the treatment. The results obtainEd are as follows: 1. After single course treatment, the cure and egg reduction rates were 83.0 and 99.1% respectively. With the second treatment, excellent results of 100% in both rates were obtained. 2. Several kinds of side effects such as dizziness, headache, etc. were complained by 29 cases (61.7 %), however, those were so mild and transient that no special treatment was necessary. 3. No significant change in laboratory findings was recognizable before and after the treatment. From the above results, it is concluded that $Distocide^{\circledR}$ is as effective and safe as $Biltricide^{\circledR}$ and highly recommendable in treatment of C. sinensis infection.

  • PDF

Comparison of hypertonic saline treatment in meningitis with cerebral edema (뇌수막염에서 발생한 뇌부종 치료에서 고장성 식염수 비교)

  • Kim, Hyung Su;Kim, Hee Ra
    • Clinical and Experimental Pediatrics
    • /
    • v.49 no.12
    • /
    • pp.1275-1281
    • /
    • 2006
  • Purpose : Cerebral edema in meningitis is a potentially complication. Hypertonic saline of various concentrations are frequently used to treat cerebral edemas in meningitis. We analyzed the safety and efficacy of osmotic therapy in cerebral edema by comparison of various hypertonic saline concentrations and mannitol. Methods : The medical records of 42 patients, who were followed up in the Department of Pediatrics, Busan Medical Center, from Jan. 2002 to Oct. 2005, were analyzed retrospectively. We measured intracranial pressure, mean flow velocity, and various laboratory parameters. Results : In cerebral edema developed in meningitis, intracranial pressure and symptoms were improved in treatment of hypertonic saline and mannitol. Serial bolus infusion of 3 percent hypertonic saline resulted in the best outcome. There was not a statistically considerable difference on the mean values of the intracranial pressure gap. On transcranial doppler, mean flow velocity was increased and pulsatilty index was decreased. Laboratory findings (osmolarity, Na, Cl, pH, lactic acid, Ca) were diffenent during the treatment period as opposed to K, Hb, bicarbonate, base excess. There was not a specific form of hypertonic saline used in meningitis treatment with cerebral edema. Conclusion : The therapy for cerebral edema in meningitis remains largely empirical. Serial bolus infusion of 3 percent hypertonic saline is better than other hypertonic salines. Various concentrations and different infusion methods of hypertonic saline statistically does not influence the result of treatment. More research aimed at improving cerebral edema treatment is needed to identify new, effective forms of treatment.

Clinical Effects of Oseltamivir in Children with Influenza in Busan, in the First Half of 2004 (2004년 상반기에 부산 지역 소아에서 유행한 독감에서 Oseltamivir의 치료 효과)

  • Park, Soo Kyoung;Choi, So Young;Kim, Sung Mi;Kim, Gil Heun;Jung, Jin Hwa;Choi, Im Jung;Cho, Kyung Soon
    • Clinical and Experimental Pediatrics
    • /
    • v.48 no.9
    • /
    • pp.976-985
    • /
    • 2005
  • Purpose : Although influenza is one of the most important causes of acute respiratory tract infections in children, effective antiviral therapies are not common and there are only a few clinical studies on treatment of influenza in children. We evaluated the efficacy of oseltamivir in the treatment of naturally aquired influenza in children during the first half of 2004 in Busan. Methods : From January 2004 to June 2004, throat swabs and nasal washes were performed and cultured for the isolation of influenza virus and tested by rapid antigen detection test(QuickVue influenza test) in children with suspected influenza infections. The children who responded positively to the QuickVue influenza test, we divided into two groups : an oseltamivir treatment group and a control group. We compared their clinical symptoms(including fever duration) and diagnosis. The medical records of patients with influenza virus infection were reviewed retrospectively. Results : A total of 621 individuals were suspected of influenza infection. Influenza viruses were isolated in 79(17.2 percent) out of 621 patients examined. QuickVue influenza tests were positive in 181 cases. The treatment group(83 individuals) received oseltamivir twice daily for 5 days, and the control group(99 individuals) were administered only symptom relief medicine. There was no differences between the two groups in clinical diagnosis and symptoms. Oseltamivir treatment reduced the fever duration and other respiratory symptoms. There were no adverse events associated with oseltamivir treatment. Conclusion : Our data suggest that oral oseltamivir treatment reduces the fever duration and other respiratory symptoms of acute influenza without side effects in children.

Characteristics of Intravenous Midazolam Sedation with Nitrous Oxide in Pediatric Dental Treatment (소아환자에서 midazolam 정주 및 아산화질소 흡입진정법 하 치과치료의 특성)

  • Kim, Hyuntae;Song, Ji-Soo;Hyun, Hong-Keun;Kim, Young-Jae;Kim, Jung-Wook;Jang, Ki-Taeg;Lee, Sang-Hoon;Shin, Teo Jeon
    • Journal of the korean academy of Pediatric Dentistry
    • /
    • v.47 no.1
    • /
    • pp.53-61
    • /
    • 2020
  • Midazolam is a short-acting benzodiazepine that is widely used in pediatric dental sedation. However, its clinical effectiveness as an intravenous sedative agent in children has not been widely documented. A retrospective study was conducted to evaluate the efficacy and safety of intravenous midazolam and nitrous oxide inhalation sedation in pediatric dental treatment. The subjects were 115 patients (118 cases) who received dental treatment under intravenous midazolam and nitrous oxide inhalation sedation. Demographic factors, general health status, sedation time, midazolam and nitrous oxide dosage, and success rate of sedation were evaluated from electronic medical records. Behavioral management was the main reason of choosing sedation. Mean duration of sedation was 56.7 minutes for surgical treatment, and 74.4 minutes for restorative treatment. The initial dosage of intravenous midazolam was 0.051 ± 0.019 mg/kg. In 34 cases (28.8%), additional midazolam of 0.036 ± 0.057 mg/kg was delivered during the treatment. The concentration of nitrous oxide was maintained between 40% and 50%. The success rate of sedation was 99% (n = 117). In 1 case, laryngospasm occurred and the patient was reversed with benzodiazepine antagonist, flumazenil. Intravenous midazolam sedation with nitrous oxide was shown to be clinically effective for the dental treatment in children, if administered by trained personnel and patients are carefully selected in accordance with guidelines.

The pharmacological treatment of patent ductus arteriosus in premature infants with respiratory distress syndrome: oral ibuprofen vs. indomethacin (호흡곤란 증후군 미숙아에서 동맥관 개존증의 약물 치료 : 경구용 ibuprofen과 indomethacin의 비교)

  • Lee, Soo Jin;Kim, Ji Young;Park, Eun Ae;Sohn, Sejung
    • Clinical and Experimental Pediatrics
    • /
    • v.51 no.9
    • /
    • pp.956-963
    • /
    • 2008
  • Purpose : Indomethacin is widely used for the prophylaxis and treatment of patent ductus arteriosus (PDA); however, it is associated with side effects such as renal failure, intraventricular hemorrhage, and gastrointestinal bleeding. Intravenous ibuprofen has been shown to be as effective as indomethacin in prompting PDA closure. If treatment with oral ibuprofen is as effective as indomethacin, it would have the advantages of greater availability, simpler administration, and lower cost. We conducted this study to compare the efficacy and side effects of indomethacin with those of oral ibuprofen, vis-$\grave{a}$-vis on the pharmacological closure of PDA. Methods : As a randomized double-blind study, 34 preterm infants with respiratory distress syndrome and hemodynamically significant PDA were treated with either intravenous indomethacin or oral ibuprofen. Echocardiography was performed by one cardiologist who was blind to the treatment that any given infant received. The rate of ductal closure, the need for additional drug treatment or surgical ligation, clinical outcome, and the side effects of drug treatment were compared. Results : Ductal closure occurred in 16 of 18 patients (88.9%) from the indomethacin group and in 14 of 16 patients (87.5%) from the ibuprofen group (P>0.05). Three patients in the indomethacin group and four in the ibuprofen group required a second drug treatment (P>0.05). Three patients (i.e., one patient in the indomethacin group and two in the ibuprofen group) underwent surgical ligation (P>0.05). Between the two groups, there was no significant difference vis-$\grave{a}$-vis in side effects or clinical outcome. Conclusion : Compared to indomethacin, oral ibuprofen has the advantages of simpler administration and lower cost, while being as effective; in addition, there are no differences between the two drug treatments with regards to side effects or clinical outcomes. Therefore, the widespread use of oral ibuprofen should be considered in treating PDA in preterm infants.